Table 1 Baseline demographic characteristics of the study population
Variables | Total (N = 2402) |
|---|---|
Age | 60.2 ± 9.6 |
Male | 1767 (73.6%) |
Height (cm) | 166.9 ± 8.6 |
Weight (kg) | 71.7 ± 12.0 |
Paroxysmal AF | 1097 (45.7%) |
Persistent AF | 1035 (43.1%) |
Hypertension | 1218 (50.7%) |
Diabetes mellitus | 434 (18.1%) |
Heart failure | 259 (10.8%) |
Ischemic stroke/TIA/SE | 219 (9.1%) |
Ischemic heart disease | 178 (7.4%) |
Any cardiomyopathies1 | 93 (3.9%) |
Valvular heart diseases | 92 (3.8%) |
History of cardiac operation | 51 (2.1%) |
Peripheral arterial disease | 19 (0.8%) |
Obstructive sleep apnea | 112 (4.7%) |
Oral anticoagulants | |
 No | 135 (5.6%) |
 Warfarin | 271 (11.3%) |
 DOAC | 1996 (83.1%) |
Antiplatelet agents | |
 No | 2273 (94.6%) |
 Single | 121 (5.0%) |
 Multiple | 8 (0.3%) |
LV ejection fraction (%) | 59.0 ± 8.5 |
LA diameter (mm) | 43.4 ± 6.7 |